NasdaqCM - Nasdaq Real Time Price • USD
Celularity Inc. (CELU)
As of 2:58 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 40,708,107 | 3 |
| Sales | 15,371,697 | 1 |
| Net Shares Purchased (Sold) | 25,336,410 | 4 |
| Total Insider Shares Held | 9.87M | -- |
| % Net Shares Purchased (Sold) | -163.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LIM KOK THAY Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.25 per share. | Indirect | 5,331,335 | Jan 12, 2024 |
| HARIRI ROBERT J Chief Executive Officer | Purchase at price 0.21 - 0.22 per share. | Direct | 3,989,556 | Oct 5, 2023 |
| SORRENTO THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.22 - 0.23 per share. | Direct | 3,441,175 | Oct 5, 2023 |
| KILCOYNE ADRIAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2023 |
| KEHLER DEAN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| SCULLEY JOHNIII Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| PARKS DIANE L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| MAZUR MARC B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| DIAMANDIS PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| VON ESCHENBACH ANDREW CHARLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| SMITH ROBIN L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| LIM KOK THAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 14, 2023 |
| HARIRI ROBERT J Chief Executive Officer | Stock Award(Grant) at price 0.59 per share. | Direct | 1,228,187 | Mar 27, 2023 |
| BRIGIDO STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| BEERS DAVID C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| HAINES JOHN R. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| GLOVER BRADLEY Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| FLETCHER KYLE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| KILCOYNE ADRIAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 17, 2023 |
| DIAMANDIS PETER Director | Conversion of Exercise of derivative security at price 0.28 per share. | Direct | 299,880 | Feb 10, 2023 |
| HARIRI ROBERT J Chief Executive Officer | Purchase at price 1.72 per share. | Direct | 17,175 | Nov 30, 2022 |
| HARIRI ROBERT J Chief Executive Officer | Purchase at price 1.71 per share. | Direct | 68,400 | Nov 29, 2022 |
| HARIRI ROBERT J Chief Executive Officer | Purchase at price 1.74 per share. | Direct | 69,600 | Nov 28, 2022 |
| SCULLEY JOHNIII Director | Conversion of Exercise of derivative security at price 0.28 per share. | Direct | 215,206 | Aug 26, 2022 |
| HARIRI ROBERT J Chief Executive Officer | Conversion of Exercise of derivative security at price 2.87 per share. | Direct | 341,740 | Aug 24, 2022 |
| KEHLER DEAN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| SCULLEY JOHNIII Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| PARKS DIANE L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| MAZUR MARC B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| DIAMANDIS PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| VON ESCHENBACH ANDREW CHARLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| SMITH ROBIN L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| JONES ANNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| LIM KOK THAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| GLOVER BRADLEY Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| FLETCHER KYLE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 13, 2022 |
| JONES ANNE Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| BRIGIDO STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| HARIRI ROBERT J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| BEERS DAVID C Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| DUNN KEARY General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| HAINES JOHN R. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| GLOVER BRADLEY Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2022 |
| STARR INTERNATIONAL COMPANY, INC. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 3.50 per share. | Indirect | 23,242,429 | Mar 1, 2022 |
| JONES ANNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 16, 2021 |
| GLOVER BRADLEY Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 16, 2021 |
| VON ESCHENBACH ANDREW CHARLES Director | Conversion of Exercise of derivative security at price 0.28 per share. | Direct | 28,000 | Nov 9, 2021 |
| KEHLER DEAN C Director | -- | Indirect | -- | Jul 16, 2021 |
| BLOOM JAY R Director | -- | Indirect | -- | Jul 16, 2021 |
| GX SPONSOR LLC. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Jul 16, 2021 |
Related Tickers
NYMXF Nymox Pharmaceutical Corporation
0.2110
-12.05%
BYSI BeyondSpring Inc.
2.7200
-8.72%
EVLO Evelo Biosciences, Inc.
0.0005
-98.77%
AFMD Affimed N.V.
4.1000
-2.15%
NAVB Navidea Biopharmaceuticals, Inc.
0.0001
0.00%
ARDS Aridis Pharmaceuticals, Inc.
0.0594
+0.68%
SRNE Sorrento Therapeutics, Inc.
0.0100
-4.76%
QBIO Q BioMed Inc.
0.0001
+9,900.00%
ELOX Eloxx Pharmaceuticals, Inc.
0.8264
-2.78%
QLGN Qualigen Therapeutics, Inc.
0.2863
-6.13%